Tamoxifen reduces plasma homocysteine levels in healthy women
1998

Tamoxifen Reduces Plasma Homocysteine Levels in Healthy Women

Sample size: 66 publication Evidence: moderate

Author Information

Author(s): M Cattaneo, L Baglietto, ML Zighetti, D Bettega, C Robertson, A Costa, PM Mannucci, A Decensi

Primary Institution: Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, IRCCS Ospedale Maggiore, University of Milano

Hypothesis

Does tamoxifen treatment lower plasma homocysteine levels in healthy women?

Conclusion

Tamoxifen decreases plasma homocysteine levels in healthy women, which may help reduce the risk of myocardial infarction.

Supporting Evidence

  • Tamoxifen treatment was associated with a significant reduction in plasma homocysteine levels.
  • Women with higher baseline homocysteine levels experienced a greater decrease.
  • The study was conducted in a double-blind, placebo-controlled manner.

Takeaway

Tamoxifen, a medication for breast cancer, can lower a substance in the blood called homocysteine, which is linked to heart problems.

Methodology

The study involved 66 healthy women who were randomized to receive either tamoxifen or placebo for 5 years, with plasma homocysteine levels measured at baseline, 2 months, and 6 months.

Limitations

The study only included women who had undergone hysterectomy and may not be generalizable to all populations.

Participant Demographics

Women aged 35 to 70 years, all had previous hysterectomy for non-malignant conditions.

Statistical Information

P-Value

0.008

Confidence Interval

(6.60 and 7.58) for tamoxifen at 6 months

Statistical Significance

p=0.008

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication